Cargando…
Comparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage
Cerebral vasospasm considered to be a serious cause of morbidity and mortality following subarachnoid haemorrhage (SAH).Despite several available therapeutic options, current protocols do not prevent major consequences of vasospasm. Inflammation is believed to play an important role in post-haemorrh...
Autores principales: | Ghodsi, Seyed Mohammad, Mohebbi, Niayesh, Naderi, Soheil, Anbarloie, Mousareza, Aoude, Ahmad, Habibi Pasdar, Seyed Sohail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277625/ https://www.ncbi.nlm.nih.gov/pubmed/25561918 |
Ejemplares similares
-
Cerebral vasospasm following traumatic subarachnoid hemorrhage
por: Aminmansour, Bahram, et al.
Publicado: (2009) -
Treatment of Intracranial Vasospasm Following Subarachnoid Hemorrhage
por: Bauer, Andrew M., et al.
Publicado: (2014) -
Diagnosis and treatment of subarachnoid hemorrhage-induced vasospasm
por: Frosini, C, et al.
Publicado: (2009) -
Subarachnoid hemorrhage and cerebral vasospasm – Literature review
por: Ciurea, AV, et al.
Publicado: (2013) -
Immunological Profile of Vasospasm after Subarachnoid Hemorrhage
por: Romoli, Michele, et al.
Publicado: (2023)